Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia: Challenges, Characteristics, and Analysis of Clinical Experience

Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia: Challenges, Characteristics, and Analysis of Clinical Experience

Background & Aims. Paroxysmal nocturnal hemoglobinuria (PNH) is a disease caused by an acquired clonal disorder of hematopoietic stem cells with clone cell membrane hypersensitivity to the complement. PNH can exist as an independent disease and can also be associated with other pathological cond...

Full description

Saved in:

Bibliographic Details
Main Authors:	ER Shilova, TV Glazanova, ZhV Chubukina, OE Rozanova, MN Zenina, AV Seltser, VI Rugal, VA Balashova, VA Kobilyanskaya, II Krobinets, VYu Udal’eva, II Zotova, LV Stelmashenko, NA Romanenko, TB Zamotina, IV Khorsheva, SV Voloshin
Format:	Article
Language:	Russian
Published:	Practical Medicine Publishing House 2019-05-01
Series:	Клиническая онкогематология
Subjects:	aplastic anemia paroxysmal nocturnal hemoglobinuria pnh phenotype pnh clone targeted therapy c3-mediated hemolysis
Online Access:	http://bloodjournal.ru/wp-content/uploads/2019/06/11.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Current status and perspectives of hematopoietic cell transplantation in patients with paroxysmal nocturnal hemoglobinuria
by: Marek Ussowicz, et al.
Published: (2025-01-01)

Striving for excellence in paroxysmal nocturnal hemoglobinuria in Canada: the EPIC program
by: Hayeong Rho, et al.
Published: (2025-07-01)

EPYSQLI (SB12; Biosimilar to Reference Eculizumab) in Asian and Non‐Asian Patients With Paroxysmal Nocturnal Hemoglobinuria: Subgroup Analysis of a Global Phase III Randomized Controlled Trial
by: Jun Ho Jang, et al.
Published: (2025-04-01)

Crovalimab: A Novel Approach in the Management of Paroxysmal Nocturnal Hemoglobinuria
by: Laiba Jalal, et al.
Published: (2025-07-01)

Clinical Manifestation and Errors in the Diagnosis of Classical Paroxysmal Nocturnal Hemoglobinuria: A clinical case series of 150 patients
by: AD Kulagin, et al.
Published: (2017-07-01)

The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment
by: Cameron Perry, et al.
Published: (2025-06-01)

Effectiveness of Iptacopan Versus C5 Inhibitors in Complement Inhibitor‐Naive Patients With Paroxysmal Nocturnal Haemoglobinuria
by: Matthew Holt, et al.
Published: (2025-06-01)

The Course of COVID-19 in a Patient with Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clone: A Case Report and Literature Review
by: Sreethish Sasi, et al.
Published: (2021-08-01)

National clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria
by: A. D. Kulagin, et al.
Published: (2014-09-01)

Viral infections and related fatal adverse events associated with complement inhibitors for PNH: a real-world pharmacovigilance analysis in FAERS
by: Jinman Zhong, et al.
Published: (2025-08-01)

Short-term recurrent coronary artery thrombosis with acute myocardial infarction in a patient with aplastic anemia–paroxysmal nocturnal hemoglobinuria syndrome: a case report
by: Xue-Guo Fu, et al.
Published: (2025-03-01)

Treatment of paroxysmal nocturnal hemoglobinuria
by: I. A. Lisukov, et al.
Published: (2014-07-01)

Classic paroxysmal nocturnal hemoglobinuria: A puzzling case of hemolytic anemia without cytopenia
by: Majed Abdul Basit Momin, et al.
Published: (2025-01-01)

Paroxysmal nocturnal hemoglobinuria: Pandora’s box?
by: Mihnea-Alexandru Găman, et al.
Published: (2020-10-01)

A case of paroxysmal nocturnal hemoglobinuria with renal hemosiderosis
by: Parimal B Patel, et al.
Published: (2019-01-01)

Meningococcal Sepsis in Patient with Paroxysmal Nocturnal Hemoglobinuria during Pegcetacoplan Therapy
by: Leo Starck, et al.
Published: (2025-03-01)

Hemoglobinuria and acute kidney injury in severe malaria: Case reports from Borgou/Alibori Teaching Hospital, Benin
by: Seraphin Ahoui, et al.
Published: (2024-10-01)

Long-term effectiveness and safety of ravulizumab in paroxysmal nocturnal hemoglobinuria: a plain language summary
by: Celso Arrais, et al.
Published: (2025-07-01)

A 2-decade survival from a double hemolytic disease: A case of paroxysmal nocturnal hemoglobinuria with hemoglobinopathy
by: Aria Namiq Chaqmachi, et al.
Published: (2024-12-01)

Hematological response in patients with paroxysmal nocturnal hemoglobinuria treated with C5-inhibitor
by: V. D. Latyshev, et al.
Published: (2024-01-01)

A method for selecting P antigen-negative red cell units for patients with paroxysmal cold hemoglobinuria
by: Geethika Sajeewani Manchanayake
Published: (2024-01-01)

Case Report: Iptacopan in a paroxysmal nocturnal hemoglobinuria patient with severe renal insufficiency
by: Ting Wu, et al.
Published: (2025-08-01)

Consensus on Complement Inhibitor Therapy and Management of Paroxysmal Nocturnal Hemoglobinuria
by: Red Blood Cell Disease (Anemia) Group, Chinese Society of Hematology, Chinese Medical Association
Published: (2025-01-01)

Primaquine-induced hemoglobinuria: a case report of a G6PD deficient malaria patient with Mahidol trait from Bandarban, Bangladesh
by: Md Fahad Zamil, et al.
Published: (2025-03-01)

Efficacy of iptacopan monotherapy for suboptimal response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria
by: Olesya U. Klimova, et al.
Published: (2025-01-01)

Paroxysmal nocturnal hemoglobinuria masquerading as hemolytic uremic syndrome: a Case Report
by: Menghan Gao, et al.
Published: (2025-07-01)

Complement C3 inhibitor in patients with paroxysmal nocturnal hemoglobinuria with suboptimal response to C5 inhibitor therapy
by: M. V. Marchenko, et al.
Published: (2024-09-01)

Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria
by: David Dingli, et al.
Published: (2024-12-01)

Paroxysmal nocturnal hemoglobinuria: the path to diagnosis
by: E. F. Makhnyr, et al.
Published: (2019-04-01)

Genetic Markers of Hereditary Thrombophilia and Risk of Thrombotic Complications in Patients with Polycythemia Vera
by: DI Shikhbabaeva, et al.
Published: (2017-01-01)

Diagnosis dan Tata Laksana Paroksismal Nokturnal Hemoglobulin
by: Laurentius A Pramono, et al.
Published: (2015-06-01)

Correlation of CD34+ Hematopoietic Stem Cells and CFU in Peripheral Blood Apheresis Products in Patients with Malignant Lymphoproliferative Diseases Before and After Cryopreservation Prior to auto-HSCT
by: VA Balashova, et al.
Published: (2018-10-01)

Clinical Experience and Perspectives of Bosutinib Use in Patients with Chronic Myeloid Leukemia
by: VA Shuvaev, et al.
Published: (2018-10-01)

Disseminated Histoplasmosis in a Patient with Aplastic Anemia
by: Sanjeev Kumar Sharma, et al.
Published: (2014-08-01)

Szczepienia ochronne u dorosłych chorych na nowotwory hematologiczne, u chorych z asplenią oraz chorych na nocną napadową hemoglobinurię– zalecenia PTHiT i sekcji do spraw zakażeń PALG
by: Iwona Hus, et al.
Published: (2025-01-01)

Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome
by: Mengying Zhang, et al.
Published: (2023-09-01)

INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA
by: Sutatta Supatharawanich, et al.
Published: (2021-06-01)

Gastric wall perforation secondary to presumed aspergillosis in a pediatric patient with aplastic anemia: A case report
by: Jesus Reyna-Figueroa, et al.
Published: (2015-04-01)

Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience
by: Monica Carpenedo, et al.
Published: (2024-12-01)

Effective treatment of refractory aplastic anemia with romiplostim after failure of multiple thrombopoietin receptor agonists: a single-center retrospective study
by: Xijuan Lin, et al.
Published: (2025-12-01)